FDA Adverse Event Malfunction Summary report: N

PENUMBRA SYSTEM 3MAX REPERFUSION CATHETER

MDR report key: 7325520 · Received March 8, 2018

Report

Report Number
3005168196-2018-00499
Event Type
Malfunction
Date Received
March 8, 2018
Date of Event
February 2, 2018
Report Date
February 7, 2018
Manufacturer
PENUMBRA, INC.
Product Code
NRY
UDI-DI
00814548012490
PMA / PMN Number
K160533
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
IT
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THIS DEVICE IS AVAILABLE FOR RETURN. A FOLLOW UP MDR WILL BE SUBMITTED UPON COMPLETION OF THE DEVICE INVESTIGATION.

Additional Manufacturer Narrative · 1

510(K) #: K160449. RESULTS: THE 3MAX WAS FRACTURED APPROXIMATELY 42.0 CM FROM THE HUB. CONCLUSIONS: EVALUATION OF THE RETURNED 3MAX REVEALED IT WAS FRACTURED. THIS DAMAGE MAY HAVE BEEN A RESULT OF FORCEFULLY ADVANCING THE DEVICE AGAINST RESISTANCE WHILE MANIPULATING AT EXTREME ANGLES OUTSIDE THE PATIENT BODY. PENUMBRA CATHETERS ARE VISUALLY INSPECTED DURING IN-PROCESS INSPECTION AND DURING QUALITY INSPECTION AFTER MANUFACTURING. THE MANUFACTURING RECORDS FOR THIS LOT WERE REVIEWED AND DID NOT REVEAL ANY OUTSTANDING DISCREPANCIES, DESIGN, OR QUALITY CONCERNS.

Description of Event or Problem · 1

THE PATIENT WAS UNDERGOING A THROMBECTOMY PROCEDURE IN THE M1 OF THE MIDDLE CEREBRAL ARTERY (MCA) USING A PENUMBRA SYSTEM 3MAX REPERFUSION CATHETER (3MAXC). DURING THE PROCEDURE, THE PHYSICIAN ATTEMPTED TO ADVANCE THE 3MAXC THROUGH A PENUMBRA SYSTEM ACE 68 REPERFUSION CATHETER (ACE68), HOWEVER THE PROXIMAL END OF THE 3MAXC STILL OUTSIDE OF THE PATIENT BROKE IN HALF, DESPITE HAVING USED A GUIDEWIRE TO ADVANCE THE 3MAXC. THE 3MAXC WAS THEREFORE RETRACTED AND REMOVED, AND THE PROCEDURE WAS COMPLETED USING A NEW 3MAXC, THE SAME ACE68 AND GUIDEWIRE. THERE WAS NO REPORT OF AN ADVERSE EFFECT TO THE PATIENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
167524 PENUMBRA SYSTEM 3MAX REPERFUSION CATHETER NRY NRY PENUMBRA, INC. F79987 00814548012490

Patients

Seq Age Sex Outcome Treatment
1 88 YR